APPROVALS ANALYSIS: Big Month For Cardio Devices, But Down Overall
This article was originally published in Clinica
Executive Summary
April was a slow month for medical device approvals, with just 46 recorded for the month on Clinica’s Medical Devices Approvals Tracker, but it was the biggest month for PMAs and PMA supplements approved by the US FDA in more than a year.
You may also be interested in...
MRI Labeling For Boston Scientific's Emblem MRI S-ICD Approved By US FDA
Boston Scientific cardiac rhythm management has been struggling to compete with MRI-compatible devices from rival Medtronic.
Earnings Winners And Losers: BSX, BCR, NUVA, NVCR
Several big names in medtech announced their second-quarter sales and earnings in late July and early August. Here are some of the companies that impressed investors and others that raised some doubts.
News We’re Watching: FDA Approves Medtronic's Affera, Roche's CGM Moves Closer To Approval, And More
Medtech Insight's News We're Watching covers medtech industry and research news you may have missed. This week, the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Florence, Italy, included new results from studies of Roche's continuous glucose monitor and Medtronic's 780G insulin pump, Medtronic moved closer to earning FDA approval for its Affera ablation mapping and ablation system, and Linus Health expanded its technology for finding signs of cognitive problems in speech data.